199 related articles for article (PubMed ID: 37910610)
1. The yeast prion protein Sup35 initiates α-synuclein pathology in mouse models of Parkinson's disease.
Meng L; Liu C; Li Y; Chen G; Xiong M; Yu T; Pan L; Zhang X; Zhou L; Guo T; Yuan X; Liu C; Zhang Z; Zhang Z
Sci Adv; 2023 Nov; 9(44):eadj1092. PubMed ID: 37910610
[TBL] [Abstract][Full Text] [Related]
2. Yeast Prion Protein Sup35 Initiates α-Synuclein Pathology in Parkinson's Disease.
Wang Y; Li H; Song N; Xie J
Mov Disord; 2024 May; 39(5):766-767. PubMed ID: 38627965
[TBL] [Abstract][Full Text] [Related]
3. Tau accelerates α-synuclein aggregation and spreading in Parkinson's disease.
Pan L; Li C; Meng L; Tian Y; He M; Yuan X; Zhang G; Zhang Z; Xiong J; Chen G; Zhang Z
Brain; 2022 Oct; 145(10):3454-3471. PubMed ID: 35552614
[TBL] [Abstract][Full Text] [Related]
4. Islet amyloid polypeptide triggers α-synuclein pathology in Parkinson's disease.
Meng L; Li Y; Liu C; Zhang G; Chen J; Xiong M; Pan L; Zhang X; Chen G; Xiong J; Liu C; Xu X; Bu L; Zhang Z; Zhang Z
Prog Neurobiol; 2023 Jul; 226():102462. PubMed ID: 37150314
[TBL] [Abstract][Full Text] [Related]
5. α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice.
Butler YR; Liu Y; Kumbhar R; Zhao P; Gadhave K; Wang N; Li Y; Mao X; Wang W
Nat Commun; 2022 Jul; 13(1):4060. PubMed ID: 35853942
[TBL] [Abstract][Full Text] [Related]
6. The prion hypothesis of Parkinson's disease.
Chu Y; Kordower JH
Curr Neurol Neurosci Rep; 2015 May; 15(5):28. PubMed ID: 25868519
[TBL] [Abstract][Full Text] [Related]
7. 27-Hydroxycholesterol Drives the Spread of α-Synuclein Pathology in Parkinson's Disease.
Dai L; Wang J; Zhang X; Yan M; Zhou L; Zhang G; Meng L; Chen L; Cao X; Zhang Z; Wang G; Zhang Z
Mov Disord; 2023 Nov; 38(11):2005-2018. PubMed ID: 37593929
[TBL] [Abstract][Full Text] [Related]
8. The yeast protein Ure2p triggers Tau pathology in a mouse model of tauopathy.
Meng L; Liu C; Liu M; Chen J; Liu C; Zhang Z; Chen G; Zhang Z
Cell Rep; 2023 Nov; 42(11):113342. PubMed ID: 37897723
[TBL] [Abstract][Full Text] [Related]
9. Copper and iron ions accelerate the prion-like propagation of α-synuclein: A vicious cycle in Parkinson's disease.
Li Y; Yang C; Wang S; Yang D; Zhang Y; Xu L; Ma L; Zheng J; Petersen RB; Zheng L; Chen H; Huang K
Int J Biol Macromol; 2020 Nov; 163():562-573. PubMed ID: 32629061
[TBL] [Abstract][Full Text] [Related]
10. The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses.
Jan A; Gonçalves NP; Vaegter CB; Jensen PH; Ferreira N
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361100
[TBL] [Abstract][Full Text] [Related]
11. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics.
Yamasaki TR; Holmes BB; Furman JL; Dhavale DD; Su BW; Song ES; Cairns NJ; Kotzbauer PT; Diamond MI
J Biol Chem; 2019 Jan; 294(3):1045-1058. PubMed ID: 30478174
[TBL] [Abstract][Full Text] [Related]
13. Seeded propagation of α-synuclein aggregation in mouse brain using protein misfolding cyclic amplification.
Nicot S; Verchère J; Bélondrade M; Mayran C; Bétemps D; Bougard D; Baron T
FASEB J; 2019 Nov; 33(11):12073-12086. PubMed ID: 31370680
[TBL] [Abstract][Full Text] [Related]
14. Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease.
Yang J; Luo S; Zhang J; Yu T; Fu Z; Zheng Y; Xu X; Liu C; Fan M; Zhang Z
Neurobiol Dis; 2021 Jan; 148():105218. PubMed ID: 33296726
[TBL] [Abstract][Full Text] [Related]
15. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
[TBL] [Abstract][Full Text] [Related]
16. The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson's disease.
Vargas JY; Grudina C; Zurzolo C
Ageing Res Rev; 2019 Mar; 50():89-101. PubMed ID: 30690184
[TBL] [Abstract][Full Text] [Related]
17. Fine Particulate Matter Triggers α-Synuclein Fibrillization and Parkinson-like Neurodegeneration.
Yuan X; Yang Y; Liu C; Tian Y; Xia D; Liu Z; Pan L; Xiong M; Xiong J; Meng L; Zhang Z; Ye K; Jiang H; Zhang Z
Mov Disord; 2022 Sep; 37(9):1817-1830. PubMed ID: 36054165
[TBL] [Abstract][Full Text] [Related]
18. C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease.
McGlinchey RP; Lacy SM; Huffer KE; Tayebi N; Sidransky E; Lee JC
J Biol Chem; 2019 Jun; 294(25):9973-9984. PubMed ID: 31092553
[TBL] [Abstract][Full Text] [Related]
19. Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson's disease.
Fares MB; Maco B; Oueslati A; Rockenstein E; Ninkina N; Buchman VL; Masliah E; Lashuel HA
Proc Natl Acad Sci U S A; 2016 Feb; 113(7):E912-21. PubMed ID: 26839406
[TBL] [Abstract][Full Text] [Related]
20. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH
Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
